Jeppson Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.91M | Buy |
10,279
+334
| +3% | +$62K | 0.66% | 37 |
|
2025
Q1 | $2.08M | Buy |
9,945
+128
| +1% | +$26.8K | 0.76% | 33 |
|
2024
Q4 | $1.74M | Sell |
9,817
-4
| -0% | -$711 | 0.63% | 40 |
|
2024
Q3 | $1.94M | Sell |
9,821
-89
| -0.9% | -$17.6K | 0.69% | 36 |
|
2024
Q2 | $1.7M | Buy |
9,910
+89
| +0.9% | +$15.3K | 0.65% | 36 |
|
2024
Q1 | $1.79M | Sell |
9,821
-287
| -3% | -$52.3K | 0.69% | 33 |
|
2023
Q4 | $1.57M | Buy |
10,108
+38
| +0.4% | +$5.89K | 0.65% | 40 |
|
2023
Q3 | $1.5M | Buy |
10,070
+262
| +3% | +$39.1K | 0.69% | 31 |
|
2023
Q2 | $1.32M | Sell |
9,808
-103
| -1% | -$13.9K | 0.58% | 43 |
|
2023
Q1 | $1.58M | Buy |
9,911
+568
| +6% | +$90.5K | 0.69% | 33 |
|
2022
Q4 | $1.51M | Buy |
9,343
+1,158
| +14% | +$187K | 0.64% | 36 |
|
2022
Q3 | $1.1M | Buy |
8,185
+1,774
| +28% | +$238K | 0.5% | 47 |
|
2022
Q2 | $982K | Buy |
6,411
+2,463
| +62% | +$377K | 0.42% | 55 |
|
2022
Q1 | $640K | Sell |
3,948
-135
| -3% | -$21.9K | 0.3% | 77 |
|
2021
Q4 | $553K | Sell |
4,083
-199
| -5% | -$27K | 0.27% | 85 |
|
2021
Q3 | $461K | Buy |
4,282
+11
| +0.3% | +$1.18K | 0.24% | 92 |
|
2021
Q2 | $481K | Buy |
4,271
+1
| +0% | +$113 | 0.26% | 86 |
|
2021
Q1 | $462K | Sell |
4,270
-28
| -0.7% | -$3.03K | 0.27% | 80 |
|
2020
Q4 | $461K | Buy |
4,298
+120
| +3% | +$12.9K | 0.31% | 77 |
|
2020
Q3 | $366K | Buy |
+4,178
| New | +$366K | 0.29% | 83 |
|